Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shanghai ChemPartner and Agios Expand Cancer Drug Collaboration

publication date: Jul 9, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai ChemPartner has expanded its drug discovery research collaboration with Agios, a Cambridge, Massachusetts biopharma seeking to develop novel drugs that target the metabolism of cancer. Agios is striving to develop drugs that inhibit the growth of tumors by starving them. The company is based on its founders’ discovery that a change in metabolism drives tumor growth, rather than the metabolism change occurring as a consequence of the cancer. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...